Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5735233 | Behavioural Brain Research | 2017 | 43 Pages |
Abstract
The current study corroborates previous evidence that the most commonly prescribed FDA-approved progestin for HT, MPA, impairs learning and memory in the ovariectomized middle-aged rat. When progestins from two different additional subcategories were investigated, NETA impaired learning and memory similarly to MPA, but LEVO enhanced learning. Future research is warranted to determine LEVO's potential as an ideal progestin for optimal health in women, including for cognition.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
B.Blair Braden, Madeline G. Andrews, Jazmin I. Acosta, Sarah E. Mennenga, Courtney Lavery, Heather A. Bimonte-Nelson,